Tryp Therapeutics announced on Wednesday that it had “submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its planned Phase 2a clinical trial investigating the effects of psilocybin-assisted psychotherapy in the treatment of patients aged 21+ suffering from Irritable Bowel Syndrome (IBS) at Massachusetts General Hospital (MGH).” The […]
Category Archives: psychedelic therapy
Lawmakers in the U.K. are warming to the idea of relaxing the restrictions on psychedelics such as psilocybin. Benzinga reports that Labor MP Charlotte Nichols “opened the discussion around the need for medical access to psilocybin-assisted therapy” by supporting “the Royal College of Psychiatrists, the Campaign Against Living Miserably (CALM), the Conservative Drug Reform Group […]
Arizona senators voted to approve a general appropriations act 2023-2024 on May 10. Within the appropriations bill is a multitude of funding proposals from the governor’s office, which includes everything from Alzheimer’s disease research ($4.1 million), a newborn screening program ($12 million), and the Arizona nurse education investment pilot program ($15 million), but it also […]
Regulators in Oregon last week announced the recipient of the state’s first license for a psilocybin service center, made possible by a voter approved measure passed nearly three years ago. The Oregon Psilocybin Services, an arm of the Oregon Health Authority, said on Friday that it had issued a license to EPIC Healing Eugene. “We […]
The Minnesota House of Representatives passed an omnibus health finance bill on April 26 with a 69-58 vote. The bill, SF-2995, contains provisions to create a Psychedelic Medicine Task Force in order to proactively prepare for legalization. The task force would be “established to advise the legislature on the legal, medical, and policy issues associated […]
Washington State’s Senate Bill 5263 was introduced on January 11, and passed on to the House on March 9. As of April 14, it received final passage from the Senate on April 14. Previously there was some concern about the House and Senate agreeing on certain amendments for SB-5263, but ultimately the new bill text […]
Patients in Australia will soon have legal access to the psychedelic drugs psilocybin and MDMA under a plan announced by regulators last month. But with no approved source of the drug available to therapists, patients will likely face bills in the tens of thousands of dollars to obtain the promising treatment. Last month, the Therapeutic […]
Advocates for the medical use of psilocybin mushrooms in Canada launched a petition to call upon the federal government to take action. Interest in psilocybin-assisted therapy continues to grow to combat end-of-life anxiety, depression, addition, and PTSD, among many other conditions. Petition e-4334 was launched on March 16—an online “Petition to the Government of Canada,” […]
Four legislators announced on March 7 that they have refiled their psychedelic therapy bill. Rep. Nancy Mace, Rep. Madeleine Dean, Sen. Cory Booker, and Sen. Rand Paul introduced the Breakthrough Therapies Act, an updated bill that would amend the Controlled Substances Act (CSA) and open up access to substances such as MDMA or psilocybin for […]
Following in the footsteps of Colorado and Oregon, Utah is the latest state to consider the benefits in therapy that psilocybin mushrooms can provide. Senate Minority Leader Luz Escamilla, (D-Salt Lake City) unveiled Senate Bill 200 on Feb. 9, a bill that would legalize psilocybin mushrooms for medical use in Utah. Deseret News reports that […]
- 1
- 2